Associate Professor Rachel Conyers is a paediatric oncologist and clinician-scientist. She has sub-specialised in childhood leukaemia, lymphoma, and bone marrow transplantation. She is the current Clinical Lead of Bone Marrow Transplantation at The Royal Children’s Hospital, Melbourne, and Group Leader of Cancer Therapies at the Murdoch Children’s Research Institute (MCRI).
A/Prof Conyers is an internationally recognised leader in pharmacogenomics and rare toxicities, exemplified by her role as Principal Investigator for the cardio toxicity working group within the Ponte De Legno Childhood Leukameia Group and representation on the Children’s Oncology Group Pharmacogenomics and Epidemiology working group (United States).
A/Prof Conyers is also an Associate Investigator with the Novo Nordisk Foundation Center for Stem Cell Medicine, reNEW. In Australia she was the lead for the MRFF funded VPCC 1.0 Pharmacogenomics Implementation and Discovery and remains Co-chair of the Pharmacogenomics Working Group in the Zero Childhood Cancer Program.
Articles featuring
A/Prof Rachel Conyers
Read our latest news
Meet more people
Get Involved
CoLaborate with us to accelerate childhood cancer research and innovation